Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and diagnostic imaging equipment and other contrast agents, including computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRiseTM and digital prediction systems that integrate data from farm equipment, satellites, field sensors, irrigation systems, drones, and other input sources and then analyze that data to allow farmers to make decisions through data science and predictive analytics. The company also exports its products. Bayer CropScience Limited was incorporated in 1958 and is based in Thane, India.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI
Target Price
The average target price of BAYERCROP.NS is 4848 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen